Gene · 3693
Papers1,722
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,722
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrins in human hepatocellular carcinoma tumorigenesis and therapy. | Chin Med J (Engl) | 2023 | 36848180 | PubTator, text mining | PubMed |
| Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade. | Cytopathology | 2023 | 36840380 | PubTator, text mining | PubMed |
| Proteomics comparison between mass-like and non-mass-like breast lesions. | Ann Transl Med | 2023 | 36819556 | PubTator, text mining | PubMed |
| Genetics of migraine: where are we now? | J Headache Pain | 2023 | 36800925 | PubTator, text mining | PubMed |
| Natural variation in gene expression and viral susceptibility revealed by neural progenitor cell villages. | Cell Stem Cell | 2023 | 36796362 | PubTator, text mining | PubMed |
| scTenifoldXct: A semi-supervised method for predicting cell-cell interactions and mapping cellular communication graphs. | Cell Syst | 2023 | 36787742 | PubTator, text mining | PubMed |
| Structure-Activity Relationships of RGD-Containing Peptides in Integrin αvβ5-Mediated Cell Adhesion. | ACS Omega | 2023 | 36777587 | PubTator, text mining | PubMed |
| Lenalidomide in Multiple Myeloma: Review of Resistance Mechanisms, Current Treatment Strategies and Future Perspectives. | Cancers (Basel) | 2023 | 36765919 | PubTator, text mining | PubMed |
| Stromal POSTN Enhances Motility of Both Cancer and Stromal Cells and Predicts Poor Survival in Colorectal Cancer. | Cancers (Basel) | 2023 | 36765564 | PubTator, text mining | PubMed |
| Bacterial RNA virus MS2 exposure increases the expression of cancer progression genes in the LNCaP prostate cancer cell line. | Oncol Lett | 2023 | 36760518 | PubTator, text mining | PubMed |
| Combination of single-cell and bulk RNA seq reveals the immune infiltration landscape and targeted therapeutic drugs in spinal cord injury. | Front Immunol | 2023 | 36742334 | PubTator, text mining | PubMed |
| Macromolecular crowding regulates matrix composition and gene expression in human gingival fibroblast cultures. | Sci Rep | 2023 | 36739306 | PubTator, text mining | PubMed |
| Enrichr in silico analysis of MS-based extracted candidate proteomic biomarkers highlights pathogenic pathways in systemic sclerosis. | Sci Rep | 2023 | 36732374 | PubTator, text mining | PubMed |
| Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types. | BMC Cancer | 2023 | 36717836 | PubTator, text mining | PubMed |
| Regulators, functions, and mechanotransduction pathways of matrix stiffness in hepatic disease. | Front Physiol | 2023 | 36711017 | PubTator, text mining | PubMed |
| Peripheral Blood Gene Expression Profile of Infants with Atopic Dermatitis. | JID Innov | 2023 | 36699197 | PubTator, text mining | PubMed |
| Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy. | Nat Cancer | 2023 | 36690875 | PubTator, text mining | PubMed |
| A Multi-Trait Association Analysis of Brain Disorders and Platelet Traits Identifies Novel Susceptibility Loci for Major Depression, Alzheimer's and Parkinson's Disease. | Cells | 2023 | 36672180 | PubTator, text mining | PubMed |
| A novel human tau knock-in mouse model reveals interaction of Abeta and human tau under progressing cerebral amyloidosis in 5xFAD mice. | Alzheimers Res Ther | 2023 | 36641439 | PubTator, text mining | PubMed |
| Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models. | Sci Transl Med | 2023 | 36630483 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3693/papers?page=12